NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
Episodes 1-15 of 245
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
Advances in MS Management: Current and Future Directions
NeuroFrontiersAdvances in MS Management: Current and Future Directions
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiersFrom Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
Metabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
NeuroFrontiersMetabolomics in Multiple Sclerosis: Advancing Diagnosis, Prognosis, and Treatment Response
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiersExploring Metabolomics in Multiple Sclerosis
Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
NeuroFrontiersSafety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events
MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
NeuroFrontiersMS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
NeuroFrontiersUnderstanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
NeuroFrontiersEmerging Technologies in MS: Neuromodulation and Myelin Regeneration
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
NeuroFrontiersMS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
Cognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
NeuroFrontiersCognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
Multiple Sclerosis Explained: Understanding Its Epidemiology
NeuroFrontiersMultiple Sclerosis Explained: Understanding Its Epidemiology
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
